Hedge Fund - Baker Bros. Advisors
Genomic Health Inc (GHDX)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2019 - Q4 (2019-12-31) | $0 | 0% | 0 | $67.89 |
| 2 | 2019 - Q3 (2019-09-30) | $626,973,000 | 4.26% | 9,244,665 | $68.68 |
| 3 | 2019 - Q2 (2019-06-30) | $538,708,000 | 3.66% | 9,260,922 | $59.24 |
| 4 | 2019 - Q1 (2019-03-31) | $714,436,000 | 4.57% | 10,198,943 | $74.15 |
| 5 | 2018 - Q4 (2018-12-31) | $756,432,000 | 6.19% | 11,744,010 | $70.10 |
| 6 | 2018 - Q3 (2018-09-30) | $968,402,000 | 6.37% | 13,790,970 | $58.50 |
| 7 | 2018 - Q2 (2018-06-30) | $695,045,000 | 5.22% | 13,790,574 | $39.68 |
| 8 | 2018 - Q1 (2018-03-31) | $431,487,000 | 3.65% | 13,789,936 | $33.18 |
| 9 | 2017 - Q4 (2017-12-31) | $471,314,000 | 4.08% | 13,781,102 | $31.88 |
| 10 | 2017 - Q3 (2017-09-30) | $442,215,000 | 3.58% | 13,780,480 | $31.54 |
| 11 | 2017 - Q2 (2017-06-30) | $448,535,000 | 3.92% | 13,779,866 | $31.68 |
| 12 | 2017 - Q1 (2017-03-31) | $433,648,000 | 3.54% | 13,770,982 | $29.58 |
| 13 | 2016 - Q4 (2016-12-31) | $404,709,000 | 3.96% | 13,770,302 | $30.49 |
| 14 | 2016 - Q3 (2016-09-30) | $398,237,000 | 3.61% | 13,770,302 | $27.86 |
| 15 | 2016 - Q2 (2016-06-30) | $353,955,000 | 3.71% | 13,668,866 | $26.56 |
| 16 | 2016 - Q1 (2016-03-31) | $338,354,000 | 3.56% | 13,659,832 | $27.44 |
| 17 | 2015 - Q4 (2015-12-31) | $480,806,000 | 3.98% | 13,659,264 | $26.78 |
| 18 | 2015 - Q3 (2015-09-30) | $289,011,000 | 2.67% | 13,658,328 | $25.77 |
| 19 | 2015 - Q2 (2015-06-30) | $379,545,000 | 3.32% | 13,657,598 | $28.21 |
| 20 | 2015 - Q1 (2015-03-31) | $417,220,000 | 3.47% | 13,656,942 | $31.79 |
| 21 | 2014 - Q4 (2014-12-31) | $436,592,000 | 4.45% | 13,656,318 | $32.55 |
| 22 | 2014 - Q3 (2014-09-30) | $386,590,000 | 4.86% | 13,655,618 | $27.88 |
| 23 | 2014 - Q2 (2014-06-30) | $374,144,000 | 4.58% | 13,654,902 | $26.62 |
| 24 | 2014 - Q1 (2014-03-31) | $359,650,000 | 4.57% | 13,654,150 | $28.69 |
| 25 | 2013 - Q4 (2013-12-31) | $399,560,000 | 5.63% | 13,650,835 | $31.73 |
| 26 | 2013 - Q3 (2013-09-30) | $417,442,000 | 5.93% | 13,650,835 | $33.44 |
| 27 | 2013 - Q2 (2013-06-30) | $432,868,000 | 8.56% | 13,650,835 | $32.84 |
| 28 | 2013 - Q1 (2013-03-31) | $355,686,000 | 7.1% | 12,577,272 | $28.52 |
| 29 | 2012 - Q4 (2012-12-31) | $336,681,000 | 8.8% | 12,359,827 | $30.18 |
| 30 | 2012 - Q3 (2012-09-30) | $388,652,000 | 8.56% | 11,203,588 | $34.53 |
| 31 | 2012 - Q1 (2012-03-31) | $316,800,000 | 8.46% | 10,349,534 | $28.83 |
| 32 | 2011 - Q4 (2011-12-31) | $222,959,000 | 7.36% | 8,781,344 | $25.10 |
| 33 | 2011 - Q3 (2011-09-30) | $172,836,000 | 7.35% | 7,863,337 | $24.32 |
| 34 | 2011 - Q2 (2011-06-30) | $219,465,000 | 8.41% | 7,863,337 | $26.41 |
| 35 | 2011 - Q1 (2011-03-31) | $183,731,000 | 7.64% | 7,468,742 | $23.33 |
| 36 | 2010 - Q4 (2010-12-31) | $143,552,000 | 6.25% | 6,711,184 | $17.73 |
The displayed share prices are average quarterly stock market prices.